Analyst Ratings for Diebold Nixdorf Inc. (DBD)Updated: 2017-07-27
Shares of Diebold Nixdorf Inc. (NYSE:DBD) have received a consensus rating of Overweight from Wall Street analysts. About 30 days ago, DBD was issued an average rating of Overweight.
Of the 9 analysts covering the stock, 6 gave it a buy rating, 0 gave an overweight rating, 3 issued a hold rating, 0 gave an underweight rating, and 0 gave a sell rating. Compared to three months ago, there has been an increase of 0 in the number of analysts with a positive outlook on the stock. During this time, the number of analysts bearish on the stock has increased by 0.
Investment analysts gave a few price targets for DBD. The most optimistic price target was 32, implying a possible profit of 38.83 percent. The most pessimistic analyst gave a price target of 26, which equates to a potential downside of 12.8 percent. It is advisable to not rely only on price targets or ratings, as these can be biased for some stocks.
Analysts have revised their earnings estimates downwards for this quarter, by about -75 percent on average, compared to last month. That number becomes -75 percent if we expand the time horizon to include the past 3 months instead of just one. Over the past 30 days, FY earnings estimates have also changed downwards by -37.68 percent. If we look at the last 90 days instead, we find a net average change of -37.87 percent in FY estimates.
Another thing investors often look at is the level of agreement among analysts' revisions. 0 analysts have revised their quarterly estimates upwards in the past 30 days, while 3 analysts revised their estimates downwards. Over the same time period, 0 analysts revised their FY earnings estimates upwards, while 3 analysts decreased their estimates.
In the trailing 52-weeks, DBD hit 31.85 at the highest peak, while it's lowest trading point was 19.95. Today's price is 15.54 percent above the 52-week low, and 27.63 percent lower than its 52-week high. DBD has a price/earnings ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The DBD value stock report compares DBD to some of its peers using value stock charts. The market cap of DBD is $1.72 billion. DBD is estimated to release their earnings results for the quarter on 0000-00-00, days from today.